stock here: it was only a matter of time….It was found that all patients that died stopped taking any further injections or boosters. 60% of the Deaths happened the same day as the injection, or the next day.
Highlights
- •We found that 73.9% of deaths were directly due to or significantly contributed to by COVID-19 vaccination.
- •Our data suggest a high likelihood of a causal link between COVID-19 vaccination and death.
- •These findings indicate the urgent need to elucidate the pathophysiologic mechanisms of death with the goal of risk stratification and avoidance of death for the large numbers of individuals who have taken or will receive one or more COVID-19 vaccines in the future.
- •This review helps provide the medical and forensic community a better understanding of COVID-19 vaccine fatal adverse events.
Table 2. Number and Proportion of Reported Causes of Death Among Included Cases.
Reported Cause of Death | Cases | Proportion of Cases (N=326) |
---|---|---|
Cardiovascular System | 158 | 48.5% |
Sudden Cardiac Death | 69 | 21.2% |
Myocardial Infarction | 31 | 9.5% |
Ischemic Heart Disease | 22 | 6.8% |
Myocarditis | 17 | 5.2% |
Coronary Artery Disease | 8 | 2.5% |
Heart Failure | 2 | 0.6% |
Aortic Dissection | 2 | 0.6% |
Cardiomyopathy | 2 | 0.6% |
Pericarditis | 1 | 0.3% |
Hypertensive Heart Disease | 1 | 0.3% |
Cor Pulmonale | 1 | 0.3% |
Coronary Postal Stenosis | 1 | 0.3% |
Ventricular Dysplasia | 1 | 0.3% |
Hematological System | 56 | 17.2% |
Pulmonary Embolism | 31 | 9.5% |
Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) | 19 | 5.8% |
Bleeding from Ruptured Aorta | 1 | 0.3% |
Coronary Thrombosis | 1 | 0.3% |
Thalassemia | 1 | 0.3% |
Systemic Capillary Leak Syndrome | 1 | 0.3% |
Thrombotic Microangiopathy | 1 | 0.3% |
Hemorrhagic Shock | 1 | 0.3% |
Respiratory System | 36 | 11% |
COVID-19 Pneumonia | 19 | 5.8% |
Respiratory Failure | 8 | 2.5% |
Bacterial Pneumonia | 4 | 1.2% |
Aspiration Pneumonia | 1 | 0.3% |
Hemopneumothorax | 1 | 0.3% |
Vaccine-Induced Acute Respiratory Distress Syndrome | 1 | 0.3% |
COVID-19 Acute Respiratory Distress Syndrome | 1 | 0.3% |
Exacerbation of Usual Interstitial Pneumonia | 1 | 0.3% |
Multiple Organ Systems | 24 | 7.4% |
Gastric Cancer | 2 | 0.6% |
COVID-19 pneumonia/Myocardial Infarction | 2 | 0.6% |
Multisystem Inflammatory Syndrome | 1 | 0.3% |
Pneumonia/brain hemorrhaging | 1 | 0.3% |
Myocardial Infarction/Respiratory Failure/Pulmonary Embolism | 1 | 0.3% |
Heart Failure/Small Bowel Ischemia | 1 | 0.3% |
Respiratory Failure/Cardiomyopathy/Encephalopathy | 1 | 0.3% |
Anaphylaxis/Hypoxic Brain Damage/Thrombosis/ Myocardial Infarction | 1 | 0.3% |
Hyperglycemic Coma | 1 | 0.3% |
Multi-Organ Failure from Cardiac Arrest | 1 | 0.3% |
Encephalitis/Myocarditis | 1 | 0.3% |
Renal/Respiratory Failure | 1 | 0.3% |
COVID-19 | 1 | 0.3% |
Adhesion Ileus | 1 | 0.3% |
Strangulation Ileus | 1 | 0.3% |
Incarceration of Inguinal Hernia | 1 | 0.3% |
Ischemic Colitis | 1 | 0.3% |
Sigmoid Colon Cancer | 1 | 0.3% |
Lung cancer | 1 | 0.3% |
Multiple Thrombosis/Rhabdomyolysis | 1 | 0.3% |
Severe Interstitial Lung Disease/Coronary Artery Disease | 1 | 0.3% |
Unknown | 1 | 0.3% |
Neurological System | 14 | 4.3% |
Cerebral Hemorrhage | 7 | 2.2% |
Subarachnoid Hemorrhage | 2 | 0.6% |
Multiple Sclerosis | 1 | 0.3% |
Cerebral Ischemia | 1 | 0.3% |
Acute Disseminated Encephalomyelitis | 1 | 0.3% |
Epilepsy | 1 | 0.3% |
Guillain-Barre Syndrome | 1 | 0.3% |
Immunological System | 13 | 4.0% |
Cytokine Storm | 4 | 1.2% |
Diabetic Ketoacidosis | 3 | 0.9% |
‘Metabolic Conditions’ | 3 | 0.9% |
Neoplasia | 2 | 0.6% |
Eosinophilia | 1 | 0.3% |
Gastrointestinal System | 3 | 0.9% |
Sigmoid Volvulus | 2 | 0.6% |
Bleeding Duodenal Ulcer | 1 | 0.3% |
Other | 22 | 6.8% |
Unexplained | 8 | 2.5% |
Drowning | 6 | 1.8% |
Head injury | 2 | 0.6% |
Sepsis | 2 | 0.6% |
Malnutrition | 1 | 0.3% |
Pyelonephritis | 1 | 0.3% |
Alcohol Intoxication | 1 | 0.3% |
Poisoning | 1 | 0.3% |